Facebook
X
LinkedIn
ForwardJournal Review in Surgical Oncology_ Melanoma
- Join the Behind the Knife Surgical Oncology Team as we discuss the PRADO and NADINA randomized control trials regarding neoadjuvant therapy in Stage III melanoma with macroscopic nodal disease!
Target Audience
- Nurses
- Nurse Practitioners
- Physicians
- Physician Assistants
Learning Objectives
- Evaluating the role of Completion Lymph Node Dissection (CLND) in patients with positive sentinel lymph nodes, specifically citing the lack of melanoma-specific survival benefit vs. the improvement in regional disease control demonstrated in the MSLT-II trial.
- Determining the appropriate surgical excision margins for primary cutaneous melanoma, comparing the outcomes of 1 cm versus 2 cm margins as analyzed in the MINT trial (Lancet 2019).
- Analyzing the impact of adjuvant systemic therapy (Anti-PD1/Immunotherapy) on recurrence-free survival in patients with resected high-risk Stage III melanoma.
Timothy Vreeland
Daniel Nelson
Alexandra Adams
Elizabeth Barbera
Joseph Broderick
Galen Gist
In support of improving patient care, Duke University Health System Clinical Education and Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team. The designation was based upon the quality of the educational activity and its compliance with the standards and policies of the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC).
- AMA PRA Category 1 Credit(s)
- ANCC
- Attendance
- JA Credit - AH
Available Credit
- 0.75 AMA PRA Category 1 Credit(s)™
- 0.75 ANCC
- 0.75 JA Credit - AH
- 0.75 Approved for AMA PRA Category 1 Credit(s)™